Examination of key cancer-associated markers revealed distinct subtype-specific expression patterns (Fig. 2B), with the proliferation marker MKI67 showing higher expression in malignant subtypes 2 and 6, while the potential stem cell marker CD44 was elevated in subtype 3. Here, CD44 is linked to cancer.